Volume 32, Issue 8 (November 2021)
Studies in Medical Sciences 2021, 32(8): 597-606 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Eftekhari A, Ezlegini F, Firoozray M. DETERMINATION OF SERUM LEVEL OF SELENOPROTEIN P AND OXIDATIVE STRESS IN TYPE 2 DIABETES PATIENTS AND THEIR CORRELATION WITH SERUM LEVEL OF GLUCOSE AND LIPID PARAMETERS AS A CASE-CONTROL STUDY. Studies in Medical Sciences 2021; 32 (8) :597-606
URL: http://umj.umsu.ac.ir/article-1-5502-en.html
URL: http://umj.umsu.ac.ir/article-1-5502-en.html
Professor, Department of Biochemistry, Islamic Azad University Shahrod Branch, shahrod, Iran (Corresponding Author) , firoozraim@yahoo.com
Abstract: (5543 Views)
Background & Aims: Type 2 diabetes (T2DM) is a complex metabolic disorder characterized by insulin resistance and progressive failure of pancreatic beta-cell function. Selenoprotein P (SelP) plays an important role in selenium homeostasis in the body and prevents oxidative stress. The aim of this study was to determine the SelP level and oxidative stress indices in serum type 2 diabetic patients and also to determine their correlation with glucose and lipid parameters.
Materials & Methods: One hundred subjects were recruited in current study, including 50 T2DM patients and 50 age, sex and BMI matched healthy controls. Blood samples were collected from all subjects. The serum SelP level was measured using ELISA kit. Serum levels of HbA1c, FBS, and lipid parameters were evaluated by autoanalyzer. In order to evaluate the serum samples for oxidative stress, total antioxidant capacity (TAC) was measured based on ferric ion reduction by Ferric Reducing Ability of Plasma (FRAP) method. Malondialdehyde was measured by fluorimetric method.
Results: The results showed that serum SelP level in type 2 diabetes was significantly higher than control group (p <0.001). Also, serum levels of TAC in the patient group decreased while levels of MDA increased significantly (p <0.001). There was a significant and direct correlation between serum SelP concentration and HbA1C, FBS, TG, VLDL-C, and MDA levels and a significant and inverse relationship between the serum concentration of SelP and serum TAC levels. Also, the TAC serum levels have a reverse and significant correlation with HbA1C, FBS, TG, VLDL-C, and TC levels. Findings showed that the serum levels of MDA have a direct and significant correlation with HbA1C, FBS, TG, and VLDL-C levels.
Conclusion: Overall, the results of this study showed that the serum level of SelP in subjects with type 2 diabetes is higher than healthy subjects, and correlates with hyperglycemic indices such as HbA1c and FBS, as well as some lipid indices (such as TG and VLDL-C) which can indicate the probable role of SelP in the pathogenesis of type 2 diabetes. Also, for the first time, findings demonstrated that serum SelP correlates with oxidative stress markers (MDA and TAC) that can indicate the probable role of SelP in pathogenesis of type 2 diabetes through oxidative stress pathways.
Materials & Methods: One hundred subjects were recruited in current study, including 50 T2DM patients and 50 age, sex and BMI matched healthy controls. Blood samples were collected from all subjects. The serum SelP level was measured using ELISA kit. Serum levels of HbA1c, FBS, and lipid parameters were evaluated by autoanalyzer. In order to evaluate the serum samples for oxidative stress, total antioxidant capacity (TAC) was measured based on ferric ion reduction by Ferric Reducing Ability of Plasma (FRAP) method. Malondialdehyde was measured by fluorimetric method.
Results: The results showed that serum SelP level in type 2 diabetes was significantly higher than control group (p <0.001). Also, serum levels of TAC in the patient group decreased while levels of MDA increased significantly (p <0.001). There was a significant and direct correlation between serum SelP concentration and HbA1C, FBS, TG, VLDL-C, and MDA levels and a significant and inverse relationship between the serum concentration of SelP and serum TAC levels. Also, the TAC serum levels have a reverse and significant correlation with HbA1C, FBS, TG, VLDL-C, and TC levels. Findings showed that the serum levels of MDA have a direct and significant correlation with HbA1C, FBS, TG, and VLDL-C levels.
Conclusion: Overall, the results of this study showed that the serum level of SelP in subjects with type 2 diabetes is higher than healthy subjects, and correlates with hyperglycemic indices such as HbA1c and FBS, as well as some lipid indices (such as TG and VLDL-C) which can indicate the probable role of SelP in the pathogenesis of type 2 diabetes. Also, for the first time, findings demonstrated that serum SelP correlates with oxidative stress markers (MDA and TAC) that can indicate the probable role of SelP in pathogenesis of type 2 diabetes through oxidative stress pathways.
References
1. Blair M. Diabetes Mellitus Review. Urol Nurs 2016;36(1):27-36. [DOI:10.7257/1053-816X.2016.36.1.27] [PMID]
2. Chikezie PC, Ojiako OA, Ogbuji AC. Oxidative stress in diabetes mellitus. Int J Biol Chem 2015;9(3):92-109. [DOI:10.3923/ijbc.2015.92.109]
3. Sen S, Chakraborty R, De B. Oxidative Stress and Diabetes Mellitus. Clin Chem Lab Med 2011;49(11):1773-82. [Google Scholar]
4. Shetty S, Copeland PR. Molecular mechanism of selenoprotein P synthesis. Biochim Biophys Acta Gen Subj 2018;1862(11):2506-10. [DOI:10.1016/j.bbagen.2018.04.011] [PMID] [PMCID]
5. Burk RF, Hill KE. Selenoprotein P expression, functions, and roles in mammals. Biochim Biophys Acta 2009;1790(11):1441-7. [DOI:10.1016/j.bbagen.2009.03.026] [PMID] [PMCID]
6. Misu H, Takamura T, Takayama H, Hayashi H, Matsuzawa-Nagata N, Kurita S, et al. A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab 2010;12(5):483-95. [DOI:10.1016/j.cmet.2010.09.015] [PMID]
7. Takayama H, Misu H, Iwama H, Chikamoto K, Saito Y, Murao K, et al. Metformin suppresses expression of the selenoprotein P gene via an AMP-activated kinase (AMPK)/FoxO3a pathway in H4IIEC3 hepatocytes. J Biol Chem 2014;289(1):335-45. [DOI:10.1074/jbc.M113.479386] [PMID] [PMCID]
8. Yang SJ, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, et al. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. J Clin Endocrinol Metab 2011;96(8):E1325-9.. [DOI:10.1210/jc.2011-0620] [PMID]
9. Ranjbar A, Khani-Jazani R, Sedighi A, Jalali-Mashayekhi F, Ghazi-Khansari M, Abdollahi M. Alteration of body total antioxidant capacity and thiol molecules in human chronic exposure to aluminum. Toxicol Environ Chem 2008;90(4):707-13. [DOI:10.1080/02772240701660650]
10. Ranjbar A, Pasalar P, Abdollahi M. Induction of oxidative stress and acetylcholinesterase inhibition in organophosphorous pesticide manufacturing workers. Hum Exp Toxicol 2002;21(4):179-82. [DOI:10.1191/0960327102ht238oa] [PMID]
11. Wang X, X Hai C. ROS acts as a double-edged sword in the pathogenesis of type 2 diabetes mellitus: is Nrf2 a potential target for the treatment? Mini Rev Med Chem 2011;11(12):1082-92. [DOI:10.2174/138955711797247761] [PMID]
12. Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes 6(3):456. [DOI:10.4239/wjd.v6.i3.456] [PMID] [PMCID]
13. Association AD. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl 1):S62. [DOI:10.2337/dc10-S062] [PMID] [PMCID]
14. Ali SA, Nassif WMH, Abdelaziz DHA. Alterations in serum levels of fetuin A and selenoprotein P in chronic hepatitis C patients with concomitant type 2 diabetes: a case-control study. Clin Res Hepatol Gastroenterol 2016;40(4):465-70. [DOI:10.1016/j.clinre.2015.12.003] [PMID]
15. Takayama H, Misu H, Iwama H, Chikamoto K, Saito Y, Murao K, et al. Metformin suppresses expression of the selenoprotein P gene via an AMP-activated kinase (AMPK)/FoxO3a pathway in H4IIEC3 hepatocytes. J Biol Chem 2014;289(1):335-45. [DOI:10.1074/jbc.M113.479386] [PMID] [PMCID]
16. Maritim AC, Sanders A, Watkins Iii JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol 2003;17(1):24-38. [DOI:10.1002/jbt.10058] [PMID]
17. Du X-L, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 2000;97(22):12222-6. [DOI:10.1073/pnas.97.22.12222] [PMID] [PMCID]
18. West IC. Radicals and oxidative stress in diabetes. Diabet Med 2000;17(3):171-80. [DOI:10.1046/j.1464-5491.2000.00259.x] [PMID]
19. Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, Berg AH, et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 2002;51(10):2951-8. [DOI:10.2337/diabetes.51.10.2951] [PMID]
20. West IC. Radicals and oxidative stress in diabetes. Diabet Med 2000;17(3):171-80. [DOI:10.1046/j.1464-5491.2000.00259.x] [PMID]
21. Sato Y, Hotta N, Sakamoto N, Matsuoka S, Ohishi N, Yagi K. Lipid peroxide level in plasma of diabetic patients. Biochem Med 1979;21(1):104-7. [DOI:10.1016/0006-2944(79)90061-9]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
